Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I A Review of the Pharmacokinetic Literature and Proposed Changes

  1. de Leon,J.
  2. Baldessarini,R.J.
  3. Balon,R.
  4. Bilbily,J.
  5. Caroff,S.N.
  6. Citrome,L.
  7. Correll,C.U.
  8. Cotes,R.O.
  9. Davis,J.M.
  10. DeLisi,L.E.
  11. Faden,J.
  12. Freudenreich,O.
  13. Goldsmith,D.R.
  14. Gurrera,R.
  15. Josiassen,R.C.
  16. Kane,J.M.
  17. Kelly,D.L.
  18. Keshavan,M.S.
  19. Laitman,R.S.
  20. Lam,Y.W.F.
  21. Leung,J.G.
  22. Love,R.C.
  23. McCollum,B.
  24. McGrane,I.R.
  25. Meyer,J.
  26. Nasrallah,H.A.
  27. Nucifora,F.C.
  28. Rothschild,A.J.
  29. Rubio,J.M.
  30. Sajatovic,M.
  31. Sarpal,D.K.
  32. Schoretsanitis,G.
  33. Shad,M.
  34. Shelton,C.
  35. Sher,L.
  36. Singh,B.
  37. Surya,S.
  38. Zarzar,T.R.
  39. Sanz,E.J.
  40. De las Cuevas,C.
  41. Show all authors +
Journal:
Journal of Clinical Psychopharmacology

ISSN: 1533-712X 0271-0749

Year of publication: 2025

Volume: 45

Issue: 3

Pages: 179-196

Type: Review

DOI: 10.1097/JCP.0000000000001987 GOOGLE SCHOLAR